DE69008466D1 - Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen. - Google Patents

Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen.

Info

Publication number
DE69008466D1
DE69008466D1 DE69008466T DE69008466T DE69008466D1 DE 69008466 D1 DE69008466 D1 DE 69008466D1 DE 69008466 T DE69008466 T DE 69008466T DE 69008466 T DE69008466 T DE 69008466T DE 69008466 D1 DE69008466 D1 DE 69008466D1
Authority
DE
Germany
Prior art keywords
dimethyluracil
piperazinyl
methoxyphenyl
propyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69008466T
Other languages
English (en)
Other versions
DE69008466T2 (de
Inventor
Masayuki Ishikawa
Hiroshi Azuma
Shigeru Ito
Tomohiro Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Showa Denko Materials Co ltd
Original Assignee
Hitachi Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16912699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69008466(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hitachi Chemical Co Ltd filed Critical Hitachi Chemical Co Ltd
Application granted granted Critical
Publication of DE69008466D1 publication Critical patent/DE69008466D1/de
Publication of DE69008466T2 publication Critical patent/DE69008466T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
DE69008466T 1989-09-06 1990-09-03 Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen. Expired - Fee Related DE69008466T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23075089 1989-09-06

Publications (2)

Publication Number Publication Date
DE69008466D1 true DE69008466D1 (de) 1994-06-01
DE69008466T2 DE69008466T2 (de) 1994-08-18

Family

ID=16912699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69008466T Expired - Fee Related DE69008466T2 (de) 1989-09-06 1990-09-03 Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen.

Country Status (8)

Country Link
US (1) US5145851A (de)
EP (1) EP0416841B1 (de)
JP (1) JPH078795B2 (de)
KR (1) KR930001808B1 (de)
AT (1) ATE104853T1 (de)
CA (1) CA2024428A1 (de)
DE (1) DE69008466T2 (de)
DK (1) DK0416841T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123025T1 (de) * 1992-07-03 1995-06-15 Synthelabo 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
FR2693195B1 (fr) * 1992-07-03 1994-09-23 Synthelabo Dérivés de 2-amino-N-[[[(4-aminocarbonyl)pyrimidin-2-yl]amino]alkyl] pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
EP0580157B2 (de) * 1992-07-23 2001-03-07 Toyota Jidosha Kabushiki Kaisha Lautstärkeregelung für ein akustisches Leitungsgerät für Fahrzeuge
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
EP1273572B9 (de) * 1997-10-09 2005-03-02 Ortho-McNeil Pharmaceutical, Inc. Mit Thiophen substituierte Piperazine für die Behandlung von benigner Prostatahyperplasie
AU2003204320B2 (en) * 1997-10-09 2006-01-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
PT1273572E (pt) * 1997-10-09 2005-03-31 Ortho Mcneil Pharm Inc Piperazinas substituidas com tiofeno uteis no tratamento da hiperplasia prostatica benigna

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755015A (fr) * 1969-08-20 1971-02-01 Byk Gulden Lomberg Chem Fab Piperazinyl-alcoylamino-uraciles substitues par un groupe aryle, leurs ethers et thioethers, ainsi que leur procede de preparation
JPS6140229A (ja) * 1984-07-19 1986-02-26 イー・アイ・デユポン・デ・ニモアス・アンド・カンパニー ２，３‐ジクロロブタンから２‐クロロブテンを製造する方法
JPS6426517A (en) * 1987-07-21 1989-01-27 Sankyo Co Remedy for dysuria

Also Published As

Publication number Publication date
KR910005867A (ko) 1991-04-27
DK0416841T3 (da) 1994-05-24
CA2024428A1 (en) 1991-03-07
EP0416841B1 (de) 1994-04-27
JPH03173819A (ja) 1991-07-29
JPH078795B2 (ja) 1995-02-01
EP0416841A3 (en) 1991-10-23
US5145851A (en) 1992-09-08
DE69008466T2 (de) 1994-08-18
KR930001808B1 (ko) 1993-03-13
ATE104853T1 (de) 1994-05-15
EP0416841A2 (de) 1991-03-13

Similar Documents

Publication Publication Date Title
NO870241D0 (no) Hypoglykemiske tiazolidindioner.
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DK140996A (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetraflour-6-alkyl-benzoesyreforbindelser
DE69121827D1 (de) Verwendung von Angiotensin-II-Antagonisten zur Herstellung eines Arzneimittels zur Behandlung von Hyperuricemie
ATE248837T1 (de) Chinuclidin-acrylamide
ATE86491T1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
NO905264L (no) Fremgangsmaate for fremstilling av biologisk aktivt protein
DE59006880D1 (de) Gerät zur Herstellung von Formkörpern und Verwendung desselben zur Herstellung von Inlays, Onlays, und Kronen in der Zahnmedizin.
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
ATE135577T1 (de) Verwendung von buspiron zur herstellung eines pharmazeutischen präparats zur behandlung der alkoholsucht
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
DE60029929D1 (de) VERWENDUNG VON PYRIDAZINO i4,5-(b)ö-INDOLE-1-ACETAMIDE DERIVATEN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON DURCH PERIPHERE BENZODIAZEPINREZEPTOREN-STÖRUNGEN VERURSACHTE KRANKHEITEN
DE69008466D1 (de) Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen.
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
DE69420679D1 (de) Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
EE9900007A (et) 2-fenüül-1,2-bensisoseleenasool-3(2H)-ooni kasutamine farmatseutilise preparaadi valmistamisel Alzheimeri tõve raviks
DE59003534D1 (de) Verfahren zur Herstellung von Triethylendiamin und Piperazin.
DE69713571D1 (de) Verwendung von (+)-alpha-(2,3-dimethoxyphenyl)-1(2-(4-fluorophenyl)ethyl-4-piperidinmethanol zur behandlung von depressionen und bipolaren erkrankungen
ATE78395T1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
ATE470671T1 (de) Verbindungen mit wachstumshormon-freisetzender eigenschaft
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee